IL1A and systemic lupus erythematosus: First attempts to block IL-1 have failed to show an adequate response in rheumatoid arthritis (RA), SLE, and osteoarthritis (18, 27), but IL-1 blockade has proven to be effective in the treatment of autoinflammatory diseases (21).